Jeremy Grantham Abbott Laboratories Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$27.2 Billion
Q1 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Abbott Laboratories stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 5,408,008 shares of ABT stock, worth $563 Million. This represents 2.26% of its overall portfolio holdings.

Number of Shares

5,408,008

Previous 4,375,357 23.6%

Holding current value

$563 Million

Previous $482 Million 27.63%

% of portfolio

2.26%

Previous 2.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $113 Million - $125 Million	1,032,651 Added 23.6%	5,408,008 $615 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $64.1 Million - $78.4 Million	710,501 Added 19.39%	4,375,357 $482 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $76.5 Million - $91.8 Million	801,191 Added 27.98%	3,664,856 $355 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $122 Million - $136 Million	1,215,172 Added 73.71%	2,863,665 $312 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $1.26 Million - $1.49 Million	13,059 Added 0.8%	1,648,493 $167 Million

Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1.5 Million - $1.76 Million	-15,800 Reduced 0.96%	1,635,434 $180 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $4.24 Million - $4.91 Million	43,860 Added 2.73%	1,651,234 $160 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $4.1 Million - $4.95 Million	-40,129 Reduced 2.44%	1,607,374 $175 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $4.71 Million - $5.74 Million	-41,277 Reduced 2.44%	1,647,503 $195 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $7.75 Million - $9.49 Million	-67,118 Reduced 3.82%	1,688,780 $238 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $2.88 Million - $3.19 Million	24,686 Added 1.43%	1,755,898 $207 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $719,266 - $846,679	6,799 Added 0.39%	1,731,212 $201 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $5.83 Million - $6.87 Million	-53,582 Reduced 3.01%	1,724,413 $207 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $13.9 Million - $15.1 Million	-132,242 Reduced 6.92%	1,777,995 $195 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $65.1 Million - $79.1 Million	710,770 Added 59.26%	1,910,237 $208 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $19.4 Million - $24.8 Million	-252,951 Reduced 17.42%	1,199,467 $110 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $22.2 Million - $32.5 Million	-353,745 Reduced 19.59%	1,452,418 $115 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $407,859 - $454,043	5,195 Added 0.29%	1,806,163 $157 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $4.32 Million - $4.68 Million	52,749 Added 3.02%	1,800,968 $151 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $6.53 Million - $7.62 Million	-89,609 Reduced 4.88%	1,748,219 $147 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $12 Million - $14.6 Million	-181,881 Reduced 9.01%	1,837,828 $147 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $16.7 Million - $18.9 Million	-255,139 Reduced 11.22%	2,019,709 $146 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $17.2 Million - $20.8 Million	-283,391 Reduced 11.08%	2,274,848 $167 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $47.6 Million - $52.5 Million	-826,002 Reduced 24.41%	2,558,239 $156 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $80.8 Million - $91.4 Million	-1,436,126 Reduced 29.79%	3,384,241 $203 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $1.78 Million - $1.91 Million	-33,200 Reduced 0.68%	4,820,367 $275 Million
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $19.1 Million - $21.4 Million	-398,392 Reduced 7.59%	4,853,567 $259 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,251,959	5,251,959 $255 Million

Others Institutions Holding ABT

# of Institutions

3,122

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account